Authors


Meagan Mayo, DO

Latest:

Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal Cohabitation

A patient presented with a history of uncontrolled HIV and a history of polysubstance use.


Jessica Irish, PharmD Candidate

Latest:

Need for Speed: Rapid Antiretroviral Initiation in the Emergency Department

Emergency departments (EDs) are an important entry point into the health care system and have been identified as a location with opportunity for increased HIV diagnosis and management.


Bennett Waxse, MD, PhD

Latest:

Improving Screening, Management of Hepatitis C in Infants and Children

Despite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.


Joseph E. Marcus, MD

Latest:

Infectious Diseases Provider Role in Extracorporeal Membrane Oxygenation Infections

There has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.



Carol Pandak, EdD

Latest:

World Polio Day: A Time to Reflect on Accomplishments, Acknowledge There’s Still Work to Do

Carol Pandak, EdD, director of PolioPlus, Rotary International, discusses the significance of this day and efforts that continue around the world to work towards eradication of this disease.


Erica K. Little, PharmD, BCIDP

Latest:

A Day Late and a Dollar Short: Managing Antimicrobial Drug Shortages

With antimicrobial drug shortages expected to continue globally, developing mitigation strategies is essential to prevent complications, including antimicrobial resistance.


Nigel McCracken, PhD

Latest:

Detecting T Cell Dysfunction in Post-Acute Infection Syndromes

Nigel McCracken, PhD, presents a diagnostic test to identify early T cell dysfunction in syndromes like Long COVID and ME/CFS, aiming to improve treatment strategies before symptoms escalate.


Scott Curry, MD

Latest:

Exploring the Recently Approved and Upcoming Clostridioides difficile Therapeutics

This market has seen a flurry of activity, as shown by a review of the latest agents.


Debika Bhattacharya, MD MSc

Latest:

The Challenges of Hepatitis B Clinical Care Within Underserved Communities

In the second part of their interview, Debika Bhattacharya, MD MSc, and Su H. Wang, MD, MPH, FACP, continue the conversation around the difficulties of getting people into care, and what the new hepatitis B guidelines hope to improve in this area.


Myriam Shaw Ojeda, PharmD

Latest:

Assisting With International Health Care Needs

Although the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.


Gerard Jacinto, PharmD

Latest:

Should Cefazolin be Prescribed in Patients With B-lactam Allergies?

For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.


Meagan Adamsick O’Brien, PharmD, BCIDP

Latest:

Defining the Characteristics of Breakthrough Invasive Fungal Infections in Hematologic Disorders

This systematic review focuses on breakthrough invasive fungal infections (bIFIs) in patients with high-risk hematological cancers, like acute leukemia, or those who have undergone stem cell transplants. Despite prophylactic antifungal treatments (usually with voriconazole or posaconazole), bIFIs remain challenging due to their complexity and high mortality rates.


Meghan Lyman, MD

Latest:

Candida auris: Coming Soon to a Facility Near You?

Epidemiologic and clinical lessons for the uninitiated.


Addison Benee Taylor, PharmD

Latest:

Multidrug Resistance in a Patient With HIV

In this case study, clinicians review a challenging case.


Amy L. Carr, PharmD, BCIDP

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Greg Mario, MBA, CEO

Latest:

Funding Isn’t Everything: Bringing Pharma to the Table for the Pasteur Act

The pharmaceutical industry faces challenges when investing in new antibiotics, which emphasizes the need for regulatory reforms, incentives, and collaborative efforts between government, healthcare organizations, and private companies. The prospective bill, the Pasteur Act, is one potential strategy to help in these areas, and incentivize pharmaceutical companies to develop these essential therapies.


Kyle H. Lee

Latest:

That’s Not Appropriate: A Look at Antibiotic Prescribing Post Discharge

Extending antimicrobial stewardship programs to transition of care and discharge may prove beneficial to reduce unnecessary antibiotic use.


Jacinda C. Abdul-Mutakabbir, PharmD, MPH

Latest:

Optimizing Vancomycin Therapy: A Review of AUC Calculation Techniques

The ideal parameter for vancomycin monitoring is the area under the curve, which can be calculated using pharmacokinetic equations or Bayesian software.


Sophia Abene

Latest:

Top 5 Infectious Disease News Stories Week of November 16-22

Recent studies show oral vancomycin reduces CDI by 64% in stem cell transplant patients, Biktarvy is effective for HIV/HBV co-infection, climate change drives rising dengue cases, and a 7-day antibiotic regimen is as effective as 14 days for bloodstream infections.


Marissa Cavaretta, PharmD, BCPS, BCACP

Latest:

Sticking It to COVID-19: The Expansion of the Pfizer-BioNTech Vaccine EUA

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.


Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.


Maureen McElligott, MD

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.


Sandra Perreand, MBA

Latest:

Lifting the Medical and Economic Burden of AMR in the US

This bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.


Elysia Burke, PharmD

Latest:

Febrile Finesse: Are We Employing Appropriate Empiric Coverage in Patients With Neutropenic Fever?

Traditional therapy coverage does not include recent data that offers some updates in evaluating the current effectiveness of empiric antibiotic treatment.


Audry Hawkins, PharmD

Latest:

SHARE the Responsibility of Antibiotic Stewardship With Our Patients

How pharmacists can use shared decision-making to improve antibiotic use.


Andrew Skinner, MD

Latest:

Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.



Alexandra L. Cunha, PharmD

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Caroline Teter, PA-C

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.

© 2024 MJH Life Sciences

All rights reserved.